zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
mycophenolate mofetil teva
teva pharma b.v. - микофенолат мофетил - Отхвърляне на присадката - Имуносупресори - Микофенолат мофетил ТЕВА е показан в комбинация с циклоспорин и кортикостероиди за профилактика на остро отхвърляне след трансплантация при пациенти, получаващи алогенни бъбречни, сърдечни или чернодробни трансплантации.
ketilept retard 150 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 150 mg prolonged - release tablets
ketilept retard 50 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 50 mg prolonged - release tablets
ketilept retard 200 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 200 mg prolonged - release tablets
ketilept retard 300 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 300 mg prolonged - release tablets
ketilept retard 400 mg prolonged - release tablets
egis pharmaceuticals plc - quentiapine - 400 mg prolonged - release tablets
transmetil 500 mg gastro - resistant tablets
mylan healthcare gmbh - Адеметионин - 500 mg gastro - resistant tablets
transmetil 500 mg powder and solvent for solution for injection
mylan healthcare gmbh - Адеметионин - 500 mg powder and solvent for solution for injection
zoletil 100
virbac - Тилетамин (под формата на хидрохлорид); zolazepam (под формата на хидрохлорид) - инжекционен разтвор - 250 mg/флакон; 250 mg/флакон - котки, кучета